Actinogen Medical Limited
ATGGF
$0.03
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 615.00K | 613.10K | 1.76M | 1.72M | -- |
| Total Revenue | 615.00K | 613.10K | 1.76M | 1.72M | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 615.00K | 613.10K | 1.76M | 1.72M | -- |
| SG&A Expenses | 1.37M | 1.36M | 1.46M | 1.43M | 1.17M |
| Depreciation & Amortization | 69.10K | 68.90K | 70.40K | 68.90K | 66.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.36M | 4.34M | 4.00M | 3.92M | 2.72M |
| Operating Income | -3.74M | -3.73M | -2.24M | -2.19M | -2.72M |
| Income Before Tax | -3.72M | -3.71M | -2.10M | -2.06M | -2.66M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.72M | -3.71M | -2.10M | -2.06M | -2.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.72M | -3.71M | -2.10M | -2.06M | -2.66M |
| EBIT | -3.74M | -3.73M | -2.24M | -2.19M | -2.72M |
| EBITDA | -3.69M | -3.68M | -2.18M | -2.14M | -2.67M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 3.15B | 3.15B | 3.04B | 3.04B | 2.92B |
| Average Diluted Shares Outstanding | 3.15B | 3.15B | 3.04B | 3.04B | 2.92B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |